Vimentin - Revision history

Michael at 04:51, 3 August 2016

2016-08-03T04:51:25Z

← Older revision		Revision as of 04:51, 3 August 2016
Line 1:		Line 1:
	[[Image:Poorly differentiated carcinoma -- vimentin - intermed mag.jpg\|thumb\|300px\|Vimentin staining in a poorly differentiated [[carcinoma]].]]		[[Image:Poorly differentiated carcinoma -- vimentin - intermed mag.jpg\|thumb\|300px\|Vimentin staining in a poorly differentiated [[carcinoma]].]]
			[[Image:Lymphoma - lung - vimentin -- intermed mag.jpg\|thumb\|300px\|Vimentin staining in a [[lymphoma]].]]
	'''Vimentin''' is a common [[immunostain]]. It marks most [[soft tissue lesions]] and [[malignant melanoma]]. It is usually negative in carcinomas.		'''Vimentin''' is a common [[immunostain]]. It marks most [[soft tissue lesions]] and [[malignant melanoma]]. It is usually negative in carcinomas.

Michael: /* Positive */

2016-08-03T01:21:39Z

Positive

← Older revision		Revision as of 01:21, 3 August 2016
Line 5:		Line 5:
	*Most [[sarcoma]]s.		*Most [[sarcoma]]s.
	*[[Malignant melanoma]].<ref name=pmid27052289>{{Cite journal \| last1 = Mısır \| first1 = AF. \| last2 = Durmuşlar \| first2 = MC. \| last3 = Zerener \| first3 = T. \| last4 = Gün \| first4 = BD. \| title = Primary malignant melanoma. \| journal = Saudi Med J \| volume = 37 \| issue = 4 \| pages = 446-9 \| month = Apr \| year = 2016 \| doi = 10.15537/smj.2016.4.15017 \| PMID = 27052289 }}</ref>		*[[Malignant melanoma]].<ref name=pmid27052289>{{Cite journal \| last1 = Mısır \| first1 = AF. \| last2 = Durmuşlar \| first2 = MC. \| last3 = Zerener \| first3 = T. \| last4 = Gün \| first4 = BD. \| title = Primary malignant melanoma. \| journal = Saudi Med J \| volume = 37 \| issue = 4 \| pages = 446-9 \| month = Apr \| year = 2016 \| doi = 10.15537/smj.2016.4.15017 \| PMID = 27052289 }}</ref>
			*[[Lymphoma]]s - many.<ref name=pmid2524200>{{Cite journal \| last1 = Domagala \| first1 = W. \| last2 = Lasota \| first2 = J. \| last3 = Chosia \| first3 = M. \| last4 = Weber \| first4 = K. \| last5 = Osborn \| first5 = M. \| title = Leukocyte-common antigen and vimentin are reliable adjuncts in the diagnosis of non-Hodgkin's lymphoma in fine needle aspirates. \| journal = Anal Quant Cytol Histol \| volume = 11 \| issue = 1 \| pages = 15-21 \| month = Feb \| year = 1989 \| doi = \| PMID = 2524200 }}</ref><ref name=pmid1711289>{{Cite journal \| last1 = Gustmann \| first1 = C. \| last2 = Altmannsberger \| first2 = M. \| last3 = Osborn \| first3 = M. \| last4 = Griesser \| first4 = H. \| last5 = Feller \| first5 = AC. \| title = Cytokeratin expression and vimentin content in large cell anaplastic lymphomas and other non-Hodgkin's lymphomas. \| journal = Am J Pathol \| volume = 138 \| issue = 6 \| pages = 1413-22 \| month = Jun \| year = 1991 \| doi = \| PMID = 1711289 }}</ref>

	===Vimentin and cytokeratin positivity===		===Vimentin and cytokeratin positivity===

Michael at 03:21, 2 August 2016

2016-08-02T03:21:30Z

← Older revision		Revision as of 03:21, 2 August 2016
Line 1:		Line 1:
	[[Image:Poorly differentiated carcinoma -- vimentin - intermed mag.jpg\|thumb\|300px\|Vimentin staining in a poorly differentiated [[carcinoma]].]]		[[Image:Poorly differentiated carcinoma -- vimentin - intermed mag.jpg\|thumb\|300px\|Vimentin staining in a poorly differentiated [[carcinoma]].]]
	'''Vimentin''' is a common [[immunostain]]. It marks most [[soft tissue lesions]] and [[malignant melanoma]]. It is usually negative in ~~carcinoma~~.		'''Vimentin''' is a common [[immunostain]]. It marks most [[soft tissue lesions]] and [[malignant melanoma]]. It is usually negative in carcinomas.

	==Positive==		==Positive==

Michael: /* Vimentin and cytokeratin positivity */

2016-08-01T23:20:47Z

Vimentin and cytokeratin positivity

← Older revision		Revision as of 23:20, 1 August 2016
Line 9:		Line 9:
	Common tumours:		Common tumours:
	*[[Renal cell carcinoma]].<ref name=pmid18318577/>		*[[Renal cell carcinoma]].<ref name=pmid18318577/>
	*[[Endometrial carcinoma]].<ref name=pmid12647218/>		*[[Endometrial carcinoma]].<ref name=pmid12647218>{{Cite journal \| last1 = Alkushi \| first1 = A. \| last2 = Irving \| first2 = J. \| last3 = Hsu \| first3 = F. \| last4 = Dupuis \| first4 = B. \| last5 = Liu \| first5 = CL. \| last6 = Rijn \| first6 = M. \| last7 = Gilks \| first7 = CB. \| title = Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray. \| journal = Virchows Arch \| volume = 442 \| issue = 3 \| pages = 271-7 \| month = Mar \| year = 2003 \| doi = 10.1007/s00428-002-0752-4 \| PMID = 12647218 }}</ref>
	*[[Ovarian serous carcinoma]].<ref name=pmid18318577>{{Cite journal \| last1 = Bahrami \| first1 = A. \| last2 = Truong \| first2 = LD. \| last3 = Ro \| first3 = JY. \| title = Undifferentiated tumor: true identity by immunohistochemistry. \| journal = Arch Pathol Lab Med \| volume = 132 \| issue = 3 \| pages = 326-48 \| month = Mar \| year = 2008 \| doi = 10.1043/1543-2165(2008)132[326:UTTIBI]2.0.CO;2 \| PMID = 18318577 }}</ref>		*[[Ovarian serous carcinoma]].<ref name=pmid18318577>{{Cite journal \| last1 = Bahrami \| first1 = A. \| last2 = Truong \| first2 = LD. \| last3 = Ro \| first3 = JY. \| title = Undifferentiated tumor: true identity by immunohistochemistry. \| journal = Arch Pathol Lab Med \| volume = 132 \| issue = 3 \| pages = 326-48 \| month = Mar \| year = 2008 \| doi = 10.1043/1543-2165(2008)132[326:UTTIBI]2.0.CO;2 \| PMID = 18318577 }}</ref>
	*[[Papillary thyroid carcinoma]].<ref name=pmid18318577/>		*[[Papillary thyroid carcinoma]].<ref name=pmid18318577/>
Line 26:		Line 26:
	Common tumours that uncommonly have the pattern:		Common tumours that uncommonly have the pattern:
	*[[Gastric adenocarcinoma]].<ref>URL: [http://cat.inist.fr/?aModele=afficheN&cpsidt=2504165 http://cat.inist.fr/?aModele=afficheN&cpsidt=2504165]. Accessed on: 26 April 2011.</ref>		*[[Gastric adenocarcinoma]].<ref>URL: [http://cat.inist.fr/?aModele=afficheN&cpsidt=2504165 http://cat.inist.fr/?aModele=afficheN&cpsidt=2504165]. Accessed on: 26 April 2011.</ref>

	==Negative==		==Negative==
	*Most [[carcinoma]]s.		*Most [[carcinoma]]s.

Michael at 23:19, 1 August 2016

2016-08-01T23:19:02Z

← Older revision		Revision as of 23:19, 1 August 2016
Line 6:		Line 6:
	*[[Malignant melanoma]].<ref name=pmid27052289>{{Cite journal \| last1 = Mısır \| first1 = AF. \| last2 = Durmuşlar \| first2 = MC. \| last3 = Zerener \| first3 = T. \| last4 = Gün \| first4 = BD. \| title = Primary malignant melanoma. \| journal = Saudi Med J \| volume = 37 \| issue = 4 \| pages = 446-9 \| month = Apr \| year = 2016 \| doi = 10.15537/smj.2016.4.15017 \| PMID = 27052289 }}</ref>		*[[Malignant melanoma]].<ref name=pmid27052289>{{Cite journal \| last1 = Mısır \| first1 = AF. \| last2 = Durmuşlar \| first2 = MC. \| last3 = Zerener \| first3 = T. \| last4 = Gün \| first4 = BD. \| title = Primary malignant melanoma. \| journal = Saudi Med J \| volume = 37 \| issue = 4 \| pages = 446-9 \| month = Apr \| year = 2016 \| doi = 10.15537/smj.2016.4.15017 \| PMID = 27052289 }}</ref>

			===Vimentin and cytokeratin positivity===
			Common tumours:
			*[[Renal cell carcinoma]].<ref name=pmid18318577/>
			*[[Endometrial carcinoma]].<ref name=pmid12647218/>
			*[[Ovarian serous carcinoma]].<ref name=pmid18318577>{{Cite journal \| last1 = Bahrami \| first1 = A. \| last2 = Truong \| first2 = LD. \| last3 = Ro \| first3 = JY. \| title = Undifferentiated tumor: true identity by immunohistochemistry. \| journal = Arch Pathol Lab Med \| volume = 132 \| issue = 3 \| pages = 326-48 \| month = Mar \| year = 2008 \| doi = 10.1043/1543-2165(2008)132[326:UTTIBI]2.0.CO;2 \| PMID = 18318577 }}</ref>
			*[[Papillary thyroid carcinoma]].<ref name=pmid18318577/>
			*[[Sarcomatoid carcinoma]] (spindle cell carcinoma).<ref name=pmid18318577/>

			Rare tumours:
			*[[Synovial sarcoma]].<ref name=pmid15338724>{{cite journal \|author=Llombart-Bosch A, Lopez-Guerrero JA, Peydro-Olaya A \|title=Synovial sarcoma (SS): new perspectives supported by modern technology \|journal=Arkh. Patol. \|volume=64 \|issue=3 \|pages=39–47 \|year=2002 \|pmid=15338724 \|doi= \|url=}}</ref>
			*[[Rhabdoid tumour]].<ref name=pmid11557780>{{cite journal \|author=Itakura E, Tamiya S, Morita K, ''et al.'' \|title=Subcellular distribution of cytokeratin and vimentin in malignant rhabdoid tumor: three-dimensional imaging with confocal laser scanning microscopy and double immunofluorescence \|journal=Mod. Pathol. \|volume=14 \|issue=9 \|pages=854–61 \|year=2001 \|month=September \|pmid=11557780 \|doi=10.1038/modpathol.3880401 \|url=http://www.nature.com/modpathol/journal/v14/n9/full/3880401a.html}}</ref>
			*[[Epithelioid sarcoma]].<ref name=pmid10452506>{{cite journal \|author=Miettinen M, Fanburg-Smith JC, Virolainen M, Shmookler BM, Fetsch JF \|title=Epithelioid sarcoma: an immunohistochemical analysis of 112 classical and variant cases and a discussion of the differential diagnosis \|journal=Hum. Pathol. \|volume=30 \|issue=8 \|pages=934–42 \|year=1999 \|month=August \|pmid=10452506 \|doi= \|url=}}</ref>
			*[[Epithelioid angiosarcoma]].<ref name=pmid18318577/>
			*[[Desmoplastic small round cell tumour]].<ref name=pmid18318577/>
			*[[Anaplastic thyroid carcinoma]].<ref name=pmid18318577/>
			*Biphasic [[malignant mesothelioma]].<ref name=pmid18318577/>
			*[[Carcinosarcoma]].<ref name=pmid18318577/>

			Common tumours that uncommonly have the pattern:
			*[[Gastric adenocarcinoma]].<ref>URL: [http://cat.inist.fr/?aModele=afficheN&cpsidt=2504165 http://cat.inist.fr/?aModele=afficheN&cpsidt=2504165]. Accessed on: 26 April 2011.</ref>
	==Negative==		==Negative==
	*Most [[carcinoma]]s.		*Most [[carcinoma]]s.

Michael at 23:12, 1 August 2016

2016-08-01T23:12:41Z

← Older revision		Revision as of 23:12, 1 August 2016
Line 1:		Line 1:
			[[Image:Poorly differentiated carcinoma -- vimentin - intermed mag.jpg\|thumb\|300px\|Vimentin staining in a poorly differentiated [[carcinoma]].]]
	'''Vimentin''' is a common [[immunostain]]. It marks most [[soft tissue lesions]] and [[malignant melanoma]]. It is usually negative in carcinoma.		'''Vimentin''' is a common [[immunostain]]. It marks most [[soft tissue lesions]] and [[malignant melanoma]]. It is usually negative in carcinoma.

Michael: Created page with "'''Vimentin''' is a common immunostain. It marks most soft tissue lesions and malignant melanoma. It is usually negative in carcinoma. ==Positive== *Most sarc..."

2016-08-01T22:37:25Z

Created page with "'''Vimentin''' is a common immunostain. It marks most soft tissue lesions and malignant melanoma. It is usually negative in carcinoma. ==Positive== *Most sarc..."

New page

'''Vimentin''' is a common [[immunostain]]. It marks most [[soft tissue lesions]] and [[malignant melanoma]]. It is usually negative in carcinoma.

==Positive==
*Most [[sarcoma]]s.
*[[Malignant melanoma]].<ref name=pmid27052289>{{Cite journal | last1 = Mısır | first1 = AF. | last2 = Durmuşlar | first2 = MC. | last3 = Zerener | first3 = T. | last4 = Gün | first4 = BD. | title = Primary malignant melanoma. | journal = Saudi Med J | volume = 37 | issue = 4 | pages = 446-9 | month = Apr | year = 2016 | doi = 10.15537/smj.2016.4.15017 | PMID = 27052289 }}</ref>

==Negative==
*Most [[carcinoma]]s.

==See also==
*[[Immunohistochemistry]].

==References==
{{Reflist|1}}

[[Category:Immunohistochemistry]]